Subscribe Register Login
Saturday, January 20, 2018, 6:46 a.m.

Jury hears of drugs’ diabetes risk

Testimony on Friday from a defense expert on endocrinology closed out the 10th day of the state’s Medicaid fraud lawsuit against Johnson & Johnson over its Risperdal medication, with both sides saying the trial is winding down.

Click here to login or subscribe below.

Archive Purchase Required

Stories older than 7-days are available in our extensive story library.

This story is only available from the Arkansas Online archives. Stories can be purchased individually after you register with the archive library.

  • Headline: Jury hears of drugs’ diabetes risk
  • Publication: Arkansas, Pages 9 on 04/07/2012
Search Archives
Benefits icon

Stay InformedKnow more about what's going on in the world, in Arkansas and in your own neighborhood.

Save MoneyThousands of dollars in savings every day with deals from our local advertisers, Arkansas' largest classifieds section and our huge Sunday coupon package.

Be EntertainedFrom movies and arts to sports and things to do on the weekend, you'll never miss out on great events and entertainment.

Available all the timeRead when you want, how you want. Access all of our coverage in print, online, on your smartphone or on your tablet computer with your subscription.

Smart DecisionsReading the newspaper gives you information that helps you make smart decisions for you and your family. Subscribing to the newspaper is an investment in yourself.